Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacy

Neurodegenerative diseases like Parkinson’s disease (PD) and Alzheimer’s disease (AD) are considered disorders of multifactorial origin, inevitably progressive and having a long preclinical period. Therefore, the availability of biological markers or biomarkers (BMs) for early disease diagnosis will...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandel, Silvia A., Morelli, Micaela, Halperin, Ilan, Korczyn, Amos D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405324/
https://www.ncbi.nlm.nih.gov/pubmed/23199065
http://dx.doi.org/10.1007/s13167-010-0036-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405324/
https://www.ncbi.nlm.nih.gov/pubmed/23199065
http://dx.doi.org/10.1007/s13167-010-0036-z

Ejemplares similares